Todd Shryock

CorWave advances heart failure treatment with a groundbreaking LVAD, showcasing promising preclinical results and paving the way for human trials.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

MIT's CircTrek device revolutionizes health monitoring by detecting individual cells in real-time, promising personalized treatments and improved patient outcomes.

Cirtec Medical expands its Costa Rica operations, enhancing global manufacturing capabilities and meeting rising demand for high-quality medical devices.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

Move expected to help expand digital health access in underserved communities

This is the first time an implantable, long-term EEG monitoring device has been authorized for use in the United States.

The company received the designation for its atrioventricular interval modulation therapy, a novel pacemaker-based treatment aimed at reducing blood pressure in patients with uncontrolled hypertension and elevated cardiovascular risk.

Device uses an adaptive algorithm to automatically adjust and correct glucose levels every five minutes around the clock.

Move positions Zimmer Biomet in the foot and ankle space

Ohio State researchers develop system that analyzes health by how they walk

Self-contained microscope system delivers single-cell resolution imaging at depths of up to 300 microns—deep enough to reach densely labeled brain regions like the entorhinal cortex and hypothalamus

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

Robotic removal of blood clots could dramatically change stroke care

Adagio Medical Receives FDA Breakthrough Device Designation for its Cryoablation System that targets VT

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

RenovoCath is designed to deliver diagnostic and therapeutic agents directly to targeted tissues, offering a localized approach to treatment that can minimize systemic exposure.

The HELM Life Sciences Cluster created to accelerate global health care innovation

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

The newly cleared system uses advanced identification and antimicrobial susceptibility testing algorithms to support the interpretation of complex microbiological data.

$8 billion division grew 4.1% for the quarter

Device can now be used in patients with symptomatic moderate-to-severe or severe mitral regurgitation who are not candidates for surgery or transcatheter edge-to-edge repair therapy.